As of November 14, 2026, Dynavax Technologies Corp has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on February 10, 2026 (Form 8-K, February 10, 2026).
29 companies changed executives this week, 1 had other signals.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| ONITY GROUP INC. | announced the departure of its Chief Investment Officer | |
| Adicet Bio, Inc. | announced the departure of its Director | |
| MAMMOTH ENERGY SERVICES, INC. | announced the departure of its Chief Operating Officer | |
| CERENOME, INC. | named a new Director | |
| Cohen & Co Inc. | named a new Chief Executive Officer |
Sell to companies like Dynavax Technologies Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Dynavax Technologies Corp reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-02-10. Every row below is cited to the filing it comes from, and this page adds each new change as Dynavax Technologies Corp files it.
Also on the record for Dynavax Technologies Corp
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| February 11, 2026 | Stake report, Schedule 13G/A, by Deep Track Capital, LP | — | 5%+ stakes | Source |
| August 25, 2025 | Stake report, Schedule 13G/A, by Deep Track Biotechnology Master Fund, Ltd. | 13.41% of the class | 5%+ stakes | Source |
| July 17, 2025 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 14.2% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Dynavax Technologies Corp now and the warning signs.
Free to see. No signup.
Keep reading
More on Dynavax Technologies Corp and the records around it.
Companies that share a holder
- Deep Track Biotechnology Master Fund, Ltd. also filed stake reports on 60 other companies: Mentari Therapeutics, Inc. (Nov 2026), Alector, Inc. (Oct 2026), TCGX Acquisition Corp. II (Oct 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Watch Dynavax Technologies Corp
Get an email when Dynavax Technologies Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Dynavax Technologies Corp?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Dynavax Technologies Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Dynavax Technologies Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-02-10 | Reported | not named in the filing | 8-K, 2026-02-10 |
New leaders reset buying decisions — get the Full Report on Dynavax Technologies Corp: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the senior executive at Dynavax Technologies Corp, with the record behind each one.
Find candidates like senior executive at Dynavax Technologies CorpEvery change, in the filing's words
Reported
Directors Effective as of the Effective Time, each of the directors of the Company (Scott Myers, Ryan Spencer, Daniel L. Kisner, M.D., Lauren Silvernail, Brent MacGregor, Elaine Sun, Francis R. Cano, Ph.D., Peter R. Paradiso, Ph.D. and Emilio Emini, Ph.D.) resigned from his or her respective position as a member of the Company's board of directors, and any committee thereof.
- As of the Effective Time, in accordance with the Merger Agreement, the sole director of Purchaser as of immediately prior to the Effective Time, Fran ois-Xavier Dazogbo, became the sole director of the Company.
- After the Effective Time, Genzyme Corporation, as sole stockholder of the Company, passed resolutions appointing Thomas Grenier and Colleen Proctor as the sole directors of the Company.
- Officers Effective as of the Effective Time the sole officer of Purchaser as of immediately prior to the Effective Time, Fran ois-Xavier Dazogbo, became the sole officer of the Company.
- After the Effective Time, Fran ois-Xavier Dazogbo, as sole director of the Company, passed resolutions appointing (or confirming the appointment of) the following individuals as officers of the Company: (i) Ryan Spencer, Chief Executive Officer, (ii) David F. Novack, President and Chief Operating Officer, (iii) Kelly MacDonald, Senior Vice President and Chief Financial Officer, (iv) John L. Slebir, Senior Vice President, General Counsel and Secretary, (v) Jamie Haney, Secretary, (vi) Fran ois-Xavier Dazogbo, Treasurer, (vii) Stephen Kalinchak, Assistant Secretary, (viii) Colleen Proctor, Vice President and (ix) Thomas Grenier, Vice President.
Tools for this story
Each opens in a new tab, filled in for Dynavax Technologies Corp. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.
